FDG-PET/CT effective for staging in new breast cancer
April 7, 2021 -- FDG-PET/CT scans are a valuable tool for staging women newly diagnosed with breast cancer, according to a study published online April 3 in Surgical Oncology. Researchers from Israel found a significant correlation between FDG uptake and breast tumor size and grade. Read More
Radium-223 treatment in men increases risk of bone fracture
April 6, 2021 -- Bone health agents should be mandatory to help prevent fractures in men who receive radionuclide therapy with radium-223 for prostate cancer, according to a study published online April 4 in Clinical Genitourinary Cancer. Read More
Keto diet improves PET/CT of cardiac sarcoidosis
April 1, 2021 -- Having patients with cardiac sarcoidosis follow a ketogenic diet for three days before their PET/CT scans can improve image quality by suppressing signal from normal myocardial activity, according to a March 26 study in the Journal of Nuclear Medicine. Read More
Researchers design 8-ring SPECT-CZT camera
March 29, 2021 -- Looking to take SPECT to the next level, researchers are developing a new system based on eight digital cadmium zinc telluride (CZT) detectors surrounding the patient. The system could offer faster scans and better image quality in patients, especially those with brain conditions. Read More
PET/CT shows link between stress and fatal heart condition
March 26, 2021 -- PET/CT has shown that increased activity in the amygdala region of the brain caused by stress can boost a person's risk of a sometimes-fatal heart condition called Takotsubo syndrome, also known as "broken heart" syndrome, according to a March 26 study in the European Heart Journal. Read More
Dutch look for answers to fix nuclear medicine training
March 26, 2021 -- Is there a way to stem the declining numbers of residents pursuing specialties in nuclear medicine in Europe and the U.S.? In a recent survey, Dutch researchers sought insights from residents on how to fix nuclear medicine training. Read More
New radiotracer for neuroendocrine tumors appears safe
March 23, 2021 -- A new radiopharmaceutical based on lutetium-177 being tested for the treatment of neuroendocrine tumors is safe and effective and may allow physicians to cut the radiation dose patients receive by half, according to a study published online March 19 in the Journal of Nuclear Medicine. Read More
Novel radiotracer shows promise for prostate imaging
March 22, 2021 -- An experimental new radiotracer is effective when used with PET/CT for detecting biochemically recurrent prostate cancer and may change patient management, according to research published online March 12 in the Journal of Nuclear Medicine. Read More
PET/MRI study looks at head injuries and Alzheimer's disease
March 18, 2021 -- PET/MRI showed in a recent study that a loss of cognitive function in older people due to head injuries that knocked them unconscious earlier in life was unrelated to pathology associated with Alzheimer's disease. Read More
When will PET/MRI live up to its promise?
March 16, 2021 -- From its early days 10 years ago to the present, PET/MRI has developed from a modality simply comparable to PET/CT to one that is changing clinical practice and becoming a potentially "killer application" in prostate cancer. Read More